These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 3541490

  • 1. Blast crisis of chronic myelogenous leukemia. Morphologic and immunological features.
    Nemoto K, Honma K, Fukuda T, Ohnishi Y.
    Acta Pathol Jpn; 1986 Oct; 36(10):1441-54. PubMed ID: 3541490
    [Abstract] [Full Text] [Related]

  • 2. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
    Shumak KH, Baker MA, Taub RN, Coleman MS.
    Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
    [Abstract] [Full Text] [Related]

  • 3. Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.
    Han T, Gomez GA, Minowada J.
    Immunology; 1978 Aug; 35(2):299-305. PubMed ID: 155646
    [Abstract] [Full Text] [Related]

  • 4. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
    Khalidi HS, Brynes RK, Medeiros LJ, Chang KL, Slovak ML, Snyder DS, Arber DA.
    Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
    [Abstract] [Full Text] [Related]

  • 5. [T lymphoid blast crisis of Philadelphia chromosome-positive chronic myeloid leukemia: analysis of 3 cases].
    Cervantes F, Urbano-Ispizua A, Escoda L, Ordi J, Montserrat E, Rozman C.
    Med Clin (Barc); 1991 Jun 01; 97(1):21-3. PubMed ID: 1857142
    [Abstract] [Full Text] [Related]

  • 6. Chronic myelocytic leukemia terminating in blast cell crisis with lymphoblastic characteristics.
    Walters TR, Minowada J, Tsubota T, Kataoka K, Han T.
    Pediatrics; 1978 Nov 01; 62(5):795-800. PubMed ID: 281667
    [Abstract] [Full Text] [Related]

  • 7. Immunological classification of chronic myeloid leukemia distinguishes chronic phase, imminent blastic transformation, and acute lymphoblastic leukemia.
    Schmetzer HM, Gerhartz HH.
    Exp Hematol; 1997 Jun 01; 25(6):502-8. PubMed ID: 9197328
    [Abstract] [Full Text] [Related]

  • 8. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z, Takahashi M, Aoki S, Toba K, Liu A, Osman Y, Takahashi H, Tsukada N, Suzuki N, Nikkuni K, Furukawa T, Koike T, Aizawa Y.
    J Exp Clin Cancer Res; 1998 Sep 01; 17(3):251-8. PubMed ID: 9894758
    [Abstract] [Full Text] [Related]

  • 9. Cell population analysis of a heterogeneous blast cell crisis of chronic myelogenous leukemia.
    Pedraza MA, Mason D, Doslu FA, Marsh RA, Boblett JP.
    Diagn Immunol; 1984 Sep 01; 2(1):19-24. PubMed ID: 6594209
    [Abstract] [Full Text] [Related]

  • 10. Role of immunophenotyping in characterisation of blast crisis of chronic myeloid leukemia--a study of 25 cases.
    Padmanabhan V, Varma N, Dash S, Varma S.
    Indian J Pathol Microbiol; 1996 Jan 01; 39(1):13-7. PubMed ID: 8755126
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. ["Lymphoid" blastic transformation in chronic myelogenous leukemia. Report of three cases (author's transl)].
    Bauters F, Jouet JP, Huart JJ, Jude B, Toussaint B, Goudemand M.
    Sem Hop; 1982 Jan 07; 58(1):17-23. PubMed ID: 6275542
    [Abstract] [Full Text] [Related]

  • 14. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
    Liu XL, Zhou SY, Du QF, Zheng WY, Zhang S, Song LL, Xu B, Liu QF, Meng FY.
    Ai Zheng; 2004 Apr 07; 23(4):421-5. PubMed ID: 15087031
    [Abstract] [Full Text] [Related]

  • 15. Lineage switch and multilineage involvement in two cases of pH chromosome-positive acute leukemia: evidence for a stem cell disease.
    Cuneo A, Balboni M, Piva N, Carli MG, Tomasi P, Previati R, Negrini M, Scapoli G, Spanedda R, Castoldi G.
    Haematologica; 1994 Apr 07; 79(1):76-82. PubMed ID: 15378954
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Ph1 positive myeloblastic crisis followed by Ph1 negative, bcr rearrangement positive T lymphoid crisis in a CML case].
    Matsushita K, Arima N, Fukumori J, Daitoku Y, Hidaka S, Ohtsubo H, Tanaka H.
    Rinsho Ketsueki; 1993 Mar 07; 34(3):348-54. PubMed ID: 8479087
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.